Viemed Healthcare Inc. held its Annual General and Special Meeting of Shareholders on June 5, 2025. Shareholders approved the election of seven director nominees. The appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2025, was also approved. Additionally, an amendment to the 2024 Long Term Incentive Plan was ratified, confirming changes to the maximum number of common shares available for issuance and clarifying vesting treatment in the event of a change in control.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.